InMed Pharmaceuticals Inc. (inm) Misses Q2 EPS by 364c

InMed Pharmaceuticals Inc. (NASDAQ: inm) reported Q2 EPS of ($3.64). Revenue for the quarter came in at $1.11 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (inm) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• Matrix Service wins FEED contract for Texas refinery tank farm
• Destination XL Group names Jimmy Olsson as chief growth officer